Article Information
PubMed
Published By
Print ISSN
Online ISSN
History
- Published online October 3, 2016.
Article Versions
- previous version (August 11, 2016 - 05:59).
- You are viewing the most recent version of this article.
Copyright & Usage
© PDA, Inc. 2016
Author Information
Cited By...
Jump to section
- Article
- Introduction
- (1) Implementation of Modular Claims for the Clearance of Xenotropic Murine Leukemia Virus (XMuLV) by Low-pH Inactivation and Virus-Retentive Filtration (Michael Clark, AbbVie Bioresearch Center, Worcester, MA)
- Low-pH Inactivation
- Virus-Retentive Filtration
- (2) The Use of Viresolve Pro in a Modular Viral Clearance Process (Dan LaCasse; Pfizer, Andover, MA)
- (3) ASTM and the Development of Standards for Virus Removal and/or Inactivation (Bob Steininger)
- (4) Virus Filtration QbD (Rachel Specht; Genentech, South San Francisco, CA)
- (5) Viral Safety Considerations in Dual Sourcing of Raw Materials in Downstream Processing (Stefan Hepbildikler; Roche, Penzberg, Germany)
- Summary
- References
- Figures & Data
- References
- Info & Metrics
Related Articles
Cited By...
- No citing articles found.